Key Takeaways
- Health Canada published the recall on October 1, 2026, covering specific Boston Scientific Direxion and Direxion HI-FLO Microcatheters.
- The manufacturing issue may cause difficulty withdrawing the device from its carrier hoop or advancing and withdrawing it through a guide catheter.
- The recall is classified as Type II, and Health Canada advises healthcare professionals to contact Boston Scientific for additional information.
Health Canada Recalls Boston Scientific Microcatheters Over Medical Device Performance Issue
Health Canada has published a medical device recall involving specific Boston Scientific Direxion and Direxion HI-FLO Microcatheters after the manufacturer identified a manufacturing issue that may affect how the devices are withdrawn and used through guide catheters.
The official recall was published by Health Canada on October 1, 2026. The recall is identified as RA-82710 and is classified as a Type II health product recall.
What Products Are Affected?
The recall covers selected Direxion and Direxion HI-FLO Microcatheters manufactured by Boston Scientific Corporation.
Affected products include several Direxion Torqueable Microcatheter models, Direxion Hi-Flo Torqueable Microcatheters and pre-loaded systems using Transend-14 and Fathom-16 configurations.
Health Canada's notice provides specific model and catalogue numbers for the affected devices. Some products have lot or serial numbers that require healthcare providers to contact the manufacturer to determine whether individual units are included.
The recall does not apply to every Direxion or Direxion HI-FLO Microcatheter. Healthcare professionals should therefore verify the product model and relevant lot or serial information against the official recall notice.
What Is the Manufacturing Issue?
According to Health Canada, Boston Scientific is removing specific lots because of a manufacturing issue that may create difficulty withdrawing the device from its carrier hoop.
The issue may also make it difficult to advance or withdraw the microcatheter through a guide catheter.
These functions are important during procedures where healthcare professionals need to position and manipulate a microcatheter through another catheter system. Any difficulty with advancement or withdrawal can affect device handling during a medical procedure.
Health Canada's notice identifies the issue as a medical-device performance problem rather than providing a general warning about every product in the product family.
What Should Healthcare Professionals Do?
Health Canada lists healthcare professionals as the audience for the recall and advises them to contact the manufacturer if they require additional information.
Because the affected products are used in healthcare settings, facilities and professionals should check their inventory against the models and lot or serial information listed in the official notice.
The Health Canada recall record contains an extensive list of affected catalogue numbers. Where the notice indicates that more than 10 lot or serial numbers are involved, healthcare professionals are directed to contact Boston Scientific for the relevant identification information.
Why the Recall Matters
Medical-device recalls are designed to address identified problems before they create broader risks for patients or healthcare providers.
In this case, the concern relates specifically to the performance and handling of certain microcatheters. The official notice gives healthcare professionals a way to identify potentially affected products and obtain further information from the manufacturer.
The recall also demonstrates why accurate model and lot-level identification is important. A broad product name alone does not establish whether a particular device is affected.
TwikUp's Perspective
The key point for healthcare organizations is precision. This is not a blanket recall of every Boston Scientific microcatheter. The official notice identifies specific models and lots, making inventory verification essential.
For hospitals and clinical teams, maintaining accurate device records can help connect manufacturer safety notices with products actually held in inventory. That process can reduce uncertainty when a recall affects a large product family containing multiple configurations.
The official Health Canada notice should remain the reference point for determining whether a particular device is affected and what information should be obtained from Boston Scientific.
What Happens Next?
Boston Scientific is removing the affected lots identified in the recall. Healthcare professionals who need additional information are advised by Health Canada to contact the manufacturer.
Hospitals and healthcare facilities using the affected product families should review the official model and lot information before deciding whether their inventory is involved.